Atlas

FDA-Inspected Site

UCB Pharma S.A.

12 FDA inspections are on record for UCB Pharma S.A. in Braine-L'Alleud, Belgium.

Clean· No action indicated

Braine-L'Alleud, Belgium · Last updated July 10, 2026

Overview

  • 12 FDA inspections are on record.
  • 5 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-02-01.

At a glance

Inspections

12

Form 483s

5

EIRs

4

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
30 Jan 2024 – 1 Feb 2024Human DrugsClean
17 Apr 2023 – 21 Apr 2023Human Drugs483On file
27 Jan 2022 – 4 Feb 2022Human Drugs483On file
23 Nov 2021 – 25 Nov 2021Human DrugsClean
20 Jan 2017 – 27 Jan 2017Human Drugs483On file
17 Mar 2016 – 23 Mar 2016Human Drugs483On file
3 Sep 2015 – 11 Sep 2015Human DrugsClean
9 Dec 2014 – 16 Dec 2014Human Drugs483View 483 →
1 Jul 2011Not recordedClean
16 Jan 2008Not recordedClean
22 Dec 2005Not recordedClean
28 Mar 2003Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

16 Dec 2014
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Jose E Melendez

Investigators

FDA investigators tied to this site in the record.

Thuy T Nguyen2 insp.
MRA M BarbosaR1 insp.
Alice S Tsao1 insp.
Madushini N Dharmasena1 insp.
Hamet M Toure1 insp.
Roger F Zabinski1 insp.
Wayne E Seifert1 insp.
MRA McCulloughJ1 insp.
Simone E Pitts1 insp.
Jacqueline M Diaz Albert1 insp.
Ephrem T Hunde1 insp.
Zhihao Pete Qiu1 insp.
Tracey L Harris1 insp.
Jose E Melendez1 insp.
Uduak M Inokon1 insp.
Azza Talaat1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind UCB Pharma S.A.'s 5 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat